Outcomes of beta blocker use in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors

BACKGROUND: In patients with cirrhosis, portal hypertension increases intestinal permeability, dysbiosis, and bacterial translocation, promoting an inflammatory state that can lead to the progression of liver disease and development of hepatocellular carcinoma (HCC). We aimed to investigate whether...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Y. Linda, van Hyfte, Grace, Özbek, Umut, Reincke, Marlene, Gampa, Anuhya, Mohamed, Yehia I., Nishida, Naoshi, Wietharn, Brooke, Amara, Suneetha, Lee, Pei-Chang, Scheiner, Bernhard, Balcar, Lorenz, Pinter, Matthias, Vogel, Arndt, Weinmann, Arndt, Saeed, Anwaar, Pillai, Anjana, Rimassa, Lorenza, Naqash, Abdul Rafeh, Muzaffar, Mahvish, Huang, Yi-Hsiang, Kaseb, Ahmed O., Kudo, Masatoshi, Pinato, David J., Ang, Celina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971987/
https://www.ncbi.nlm.nih.gov/pubmed/36865801
http://dx.doi.org/10.3389/fonc.2023.1128569

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971987/
https://www.ncbi.nlm.nih.gov/pubmed/36865801
http://dx.doi.org/10.3389/fonc.2023.1128569

Ejemplares similares